Oracle Alpha »

Ptc Therapeutics I shares owned by Oracle Alpha

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $337k 12k 27.56

More positions owned by Oracle Alpha

Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Gitlab (GTLB)
Samsara (IOT)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Snowflake Inc Cl A (SNOW)
Tesla Motors (TSLA)
Synchrony Financial (SYF)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Coinbase Global (COIN)
Procore Technologies (PCOR)
Brighthouse Finl (BHF)
Hess (HES)

View all positions for Oracle Alpha

Top funds holding Ptc Therapeutics I

Wellington Management Company
Vanguard Group
Cowen And Company
Henderson Group
Franklin Resources
D. E. Shaw & Co
Jacobs Levy Equity Management
Blackstone Group
T. Rowe Price Associates
Tang Capital Management
Voloridge Investment Management
Jane Street
Jpmorgan Chase & Co
Charles Schwab Investment Management
Norges Bank Investment Management

View all funds holding Ptc Therapeutics I